BDBM652728 4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4443

SMILES Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCCn5ccnc45)c3)ccc12

InChI Key InChIKey=PIUDHEFNICCZME-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652728   

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652728BDBM652728(US20240059691, Example 4443 | 4-chloro-N6-((2-((5,...)
Affinity DataIC50: 200nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652728BDBM652728(US20240059691, Example 4443 | 4-chloro-N6-((2-((5,...)
Affinity DataIC50: 7.00E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent